Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus
- PMID: 16914849
- DOI: 10.3233/jad-2006-9s312
Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus
Abstract
Alzheimer's disease (AD) is a progressive disorder that is characterized by the accumulation of neuropathologic lesions and neurochemical alterations. Ultrastructural investigations in many association regions of the neocortex and the hippocampal dentate gyrus have demonstrated a disease-related decline in numerical synaptic density. This decline in brain connectivity occurs early in the disease process and strongly correlates with the cognitive decline observed in AD. The synapse loss does not appear to be an inevitable consequence of the aging process. This article reviews the ultrastructural studies assessing AD-related synaptic loss and the possible compensatory changes in the synaptic complex that occur as a result of the loss in brain connectivity.
Similar articles
-
Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.Neurobiol Aging. 2003 Dec;24(8):1029-46. doi: 10.1016/j.neurobiolaging.2003.08.002. Neurobiol Aging. 2003. PMID: 14643375 Review.
-
Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.Prog Brain Res. 2002;136:467-86. doi: 10.1016/s0079-6123(02)36039-4. Prog Brain Res. 2002. PMID: 12143403 Review.
-
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.Neurobiol Aging. 2006 Oct;27(10):1372-84. doi: 10.1016/j.neurobiolaging.2005.09.012. Epub 2005 Nov 9. Neurobiol Aging. 2006. PMID: 16289476 Clinical Trial.
-
Quantitative assessment of cortical synaptic density in Alzheimer's disease.Neurobiol Aging. 1990 Jan-Feb;11(1):29-37. doi: 10.1016/0197-4580(90)90059-9. Neurobiol Aging. 1990. PMID: 2325814
-
Synaptic and neuritic alterations during the progression of Alzheimer's disease.Neurosci Lett. 1994 Jun 6;174(1):67-72. doi: 10.1016/0304-3940(94)90121-x. Neurosci Lett. 1994. PMID: 7970158
Cited by
-
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders.Int J Mol Sci. 2022 Sep 16;23(18):10831. doi: 10.3390/ijms231810831. Int J Mol Sci. 2022. PMID: 36142742 Free PMC article.
-
Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.J Neuroimmune Pharmacol. 2014 Mar;9(2):80-91. doi: 10.1007/s11481-013-9488-y. Epub 2013 Jul 6. J Neuroimmune Pharmacol. 2014. PMID: 23832285 Free PMC article. Review.
-
Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer's Disease.bioRxiv [Preprint]. 2024 Jan 24:2024.01.23.576728. doi: 10.1101/2024.01.23.576728. bioRxiv. 2024. Update in: Mol Neurodegener. 2024 Aug 6;19(1):60. doi: 10.1186/s13024-024-00749-1. PMID: 38328211 Free PMC article. Updated. Preprint.
-
Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model.Acta Neuropathol. 2016 Dec;132(6):859-873. doi: 10.1007/s00401-016-1637-y. Epub 2016 Oct 26. Acta Neuropathol. 2016. PMID: 27785573 Free PMC article.
-
Melatonin stimulates dendrite formation and complexity in the hilar zone of the rat hippocampus: participation of the Ca++/Calmodulin complex.Int J Mol Sci. 2015 Jan 16;16(1):1907-27. doi: 10.3390/ijms16011907. Int J Mol Sci. 2015. PMID: 25603176 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical